Guilin Sanjin Pharmaceutical Co Ltd Free Cash Flow Generation Index
Guilin Sanjin Pharmaceutical Co Ltd free cash flow generation index. Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-6.63 Million represents 0% of operating cash flow (CN¥117.62 Million). Check 002275 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Free cash flow generation index of Guilin Sanjin Pharmaceutical Co Ltd from 2006 to 2024. Historical FCF Generation Index trend for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. Explore 002275 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Guilin Sanjin Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2006–2024)
Guilin Sanjin Pharmaceutical Co Ltd free cash flow generation index by year from 2006 to 2024. Year-by-year Free Cash Flow Generation Index for Guilin Sanjin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Guilin Sanjin Pharmaceutical Co Ltd cash conversion from operations.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | CN¥506.16 Million | CN¥588.33 Million | CN¥82.18 Million | ▼ -0.1% |
| 2023 | 0.86x | CN¥472.85 Million | CN¥549.25 Million | CN¥76.40 Million | ▼ -2.4% |
| 2022 | 0.88x | CN¥466.40 Million | CN¥528.67 Million | CN¥62.27 Million | ▲ +36.0% |
| 2021 | 0.65x | CN¥266.15 Million | CN¥410.24 Million | CN¥144.09 Million | ▼ -1.2% |
| 2020 | 0.66x | CN¥392.52 Million | CN¥597.99 Million | CN¥205.47 Million | ▲ +26.9% |
| 2019 | 0.52x | CN¥242.14 Million | CN¥468.29 Million | CN¥226.14 Million | ▼ -38.2% |
| 2018 | 0.84x | CN¥461.76 Million | CN¥551.73 Million | CN¥89.96 Million | ▼ -0.5% |
| 2017 | 0.84x | CN¥326.29 Million | CN¥387.82 Million | CN¥61.53 Million | ▼ -4.2% |
| 2016 | 0.88x | CN¥471.49 Million | CN¥536.85 Million | CN¥65.36 Million | ▲ +28.0% |
| 2015 | 0.69x | CN¥273.48 Million | CN¥398.50 Million | CN¥125.02 Million | ▲ +46.9% |
| 2014 | 0.47x | CN¥185.25 Million | CN¥396.53 Million | CN¥211.28 Million | ▲ +11069.8% |
| 2013 | 0.00x | CN¥1.31 Million | CN¥314.16 Million | CN¥312.85 Million | ▼ -98.7% |
| 2012 | 0.32x | CN¥96.96 Million | CN¥302.59 Million | CN¥205.63 Million | ▼ -49.0% |
| 2011 | 0.63x | CN¥214.30 Million | CN¥341.05 Million | CN¥126.75 Million | ▼ -4.1% |
| 2010 | 0.66x | CN¥187.05 Million | CN¥285.49 Million | CN¥98.44 Million | ▼ -22.9% |
| 2009 | 0.85x | CN¥308.61 Million | CN¥363.29 Million | CN¥54.68 Million | ▲ +6.5% |
| 2008 | 0.80x | CN¥152.33 Million | CN¥190.97 Million | CN¥38.64 Million | ▼ -10.7% |
| 2007 | 0.89x | CN¥146.80 Million | CN¥164.39 Million | CN¥17.59 Million | ▲ +3.1% |
| 2006 | 0.87x | CN¥188.51 Million | CN¥217.67 Million | CN¥29.16 Million | — |